| WB | 1/500 - 1/2000 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 1/200 - 1/1000 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 1/200 - 1/400 | Human,Mouse,Rat |
| Elisa | 1/10000 | Human,Mouse,Rat |
| Aliases | K5; KRT5; DDD; EBS2; KRT5A |
| Entrez GeneID | 3852 |
| clone | 2C2B4 |
| WB Predicted band size | 62.3kDa |
| Host/Isotype | Mouse IgG1 |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | Purified recombinant fragment of human CK5 (AA: 316-590) expressed in E. Coli. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide |
+ +
以下是关于CK5抗体的3篇参考文献及其摘要信息：
---
1. **文献名称**：*Cytokeratin 5/6 immunohistochemical expression in breast carcinomas*
**作者**：Livasy CA, Perou CM, Karaca G, et al.
**摘要**：研究CK5/6抗体在乳腺癌中的表达模式，证实其作为基底样乳腺癌的特异性标记物，与激素受体阴性及较差的临床预后相关。
---
2. **文献名称**：*Utility of cytokeratin 5/6 in the differential diagnosis of benign and malignant papillary lesions of the breast*
**作者**：Tse GM, Tan PH, Lui PC, et al.
**摘要**：探讨CK5抗体在乳腺乳头状病变鉴别诊断中的应用，发现CK5阴性表达有助于区分良性乳头状瘤与恶性乳头状癌。
---
3. **文献名称**：*Cytokeratin 5 positivity predicts response to platinum-based chemotherapy in triple-negative breast cancer*
**作者**：Rakha EA, El-Sayed ME, Reis-Filho JS, et al.
**摘要**：通过CK5抗体标记分析三阴性乳腺癌，发现CK5阳性患者对铂类化疗敏感性更高，提示其作为治疗反应的潜在预测标志物。
---
4. **文献名称**：*Comparative analysis of CK5 and P63 antibodies in identifying myoepithelial cells in breast lesions*
**作者**：Dabbs DJ, Goyal A, Bshara W, et al.
**摘要**：比较CK5与P63抗体在乳腺病变中识别肌上皮细胞的效果，证实CK5对基底细胞层的高特异性，适用于病理诊断中的肌上皮标记。
---
以上文献均聚焦CK5抗体在肿瘤分型、诊断及治疗中的临床应用，提供关键病理学依据。
×
